3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
11
Colorectal Neoplasms
10
Neoplasm Metastasis
6
Rhabdomyosarcoma
3
Neuroblastoma
3
Lung Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Solid Tumors
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Refractory Solid Tumors
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Medulloblastoma
1
Malignant mesenchymal tumor
1
Intestinal Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Cisplatin
1
Cerebral Decortication
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Irinotecan
×
30 days
×
Clear all
No trials found.